{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:42:59Z","timestamp":1792082579861,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T00:00:00Z","timestamp":1485561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MC_PC_15103"],"award-info":[{"award-number":["MC_PC_15103"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MR\/K000551\/1"],"award-info":[{"award-number":["MR\/K000551\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MR\/M01360X\/1"],"award-info":[{"award-number":["MR\/M01360X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MR\/N010469\/1"],"award-info":[{"award-number":["MR\/N010469\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"crossref","award":["BB\/J014567\/1"],"award-info":[{"award-number":["BB\/J014567\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpddr.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T15:46:18Z","timestamp":1489074378000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes"],"prefix":"10.1016","volume":"7","author":[{"given":"Ana Rita","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7818-2348","authenticated-orcid":false,"given":"Matt","family":"Ravenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Diez","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Talman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cally","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8985-9265","authenticated-orcid":false,"given":"Taane G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1403-6138","authenticated-orcid":false,"given":"Susana","family":"Campino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2017.03.001_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/pgs.10.165","article-title":"How can we identify parasite genes that underlie antimalarial drug resistance?","volume":"12","author":"Anderson","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A\u00a0molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A\u00a0novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baraga\u00f1a","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.chembiol.2011.09.016","article-title":"Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors","volume":"18","author":"Dong","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery \u2014 approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/cb500616x","article-title":"Mutations in the P-Type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials","volume":"10","author":"Flannery","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nbt.2925","article-title":"Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system","volume":"32","author":"Ghorbal","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3575","article-title":"The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs","volume":"7","author":"Herman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented synthesis yields novel multistage antimalarial inhibitors","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00696-16","article-title":"Mutations in the Plasmodium falciparum cyclic amine resistance locus (PfCARL) confer multidrug resistance","volume":"7","author":"LaMonte","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib11","doi-asserted-by":"crossref","first-page":"16166","DOI":"10.1038\/nmicrobiol.2016.166","article-title":"UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes","volume":"1","author":"Lim","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib14","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijpddr.2017.03.001_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12936-016-1634-6","article-title":"Characterizing the impact of sustained sulfadoxine\/pyrimethamine use upon the Plasmodium falciparum population in malawi","volume":"15","author":"Ravenhall","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib16","doi-asserted-by":"crossref","first-page":"17980","DOI":"10.1074\/jbc.M114.558353","article-title":"In\u00a0Vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth","volume":"289","author":"Ross","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2017.03.001_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."}],"updated-by":[{"DOI":"10.1016\/j.ijpddr.2017.11.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000}}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T13:54:09Z","timestamp":1535982849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2211320717300131"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.03.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727478309.793548628","asserted-by":"object"}]},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}